Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE) Cristina Carbonell , Miguel Marcos , Alfredo Guillén-Del-Castillo , Manuel Rubio-Rivas , Ana Argibay , Adela Marín-Ballvé , Ignasi Rodríguez-Pintó , Maria Baldà-Masmiquel , Eduardo Callejas-Moraga , Dolores Colunga , Luis Sáez-Comet , Cristina González-Echávarri , Norberto Ortego-Centeno , Begoña Marí-Alfonso , José-Antonio Vargas-Hitos , José-Antonio Todolí-Parra , Luis Trapiella , María-Teresa Herranz-Marín , Mayka Freire , Antoni Castro-Salomó , Isabel Perales-Fraile , Ana-Belén Madroñero-Vuelta , María-Esther Sánchez-García , Manuel Ruiz-Muñoz , Andrés González-García , Jorge Sánchez-Redondo , Gloria de-la-Red-Bellvis , Alejandra Fernández-Luque , Alberto Muela-Molinero , Gema-María Lledó , Carles Tolosa-Vilella , Vicent Fonollosa-Pla , Antonio-Javier Chamorro , Carmen-Pilar Simeón-Aznar Autoimmunity Reviews(2022)
摘要
•Systemic sclerosis patients have increased risk of lung, breast, and blood cancer.•Primary biliary cholangitis is linked to a 6-fold greater risk of breast cancer.•Moderate or severe interstitial lung disease is linked to a higher risk of cancer.•Anti-centromere antibodies are associated with a lower risk of cancer.
更多 查看译文
关键词
Systemic sclerosis, Cancer, Anticentromere antibody, Primary biliary cholangitis
AI 理解论文
溯源树
样例